Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Courting a cure for fragile X.

Gül Dölen1, Mark F Bear

  • 1Howard Hughes Medical Institute, The Picower Center for Learning and Memory, Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Neuron
|March 8, 2005
PubMed
Summary

Fragile X syndrome, a genetic cause of intellectual disability, may be treated by blocking specific brain receptors. Studies show that targeting group I metabotropic glutamate receptors (mGluRs) can improve memory and behavior in a fruit fly model.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circuit dynamics of binocular conflict in mouse primary visual cortex.

Frontiers in systems neuroscience·2026
Same author

Schizophrenia-associated glycoprotein Adamtsl3 regulates perineuronal net formation, maintenance, and adult cortical plasticity.

Molecular psychiatry·2026
Same author

Dose-Response Characteristics of Retinal Inactivation Due to Intravitreal Injections of Tetrodotoxin in Nonhuman Primates.

Investigative ophthalmology & visual science·2026
Same author

The Emerging Neurobiology of Psychedelics: Critical Periods, Metaplasticity, and Extracellular Matrix Remodeling.

Annual review of neuroscience·2026
Same author

Tuning metaplasticity in the adult visual cortex using flickering light.

bioRxiv : the preprint server for biology·2026
Same author

A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1<sup>-/y</sup> mice.

Nature communications·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Fragile X syndrome is the leading inherited cause of intellectual disability.
  • Overactive signaling of group I metabotropic glutamate receptors (mGluRs) is implicated in Fragile X syndrome symptoms.

Purpose of the Study:

  • To investigate if targeting group I metabotropic glutamate receptors (mGluRs) can alleviate Fragile X syndrome-related defects.
  • To test the hypothesis that mGluR overactivity contributes to the pathophysiology of Fragile X syndrome.

Main Methods:

  • Utilized a Drosophila melanogaster model to study Fragile X syndrome.
  • Administered metabotropic glutamate receptor (mGluR) antagonists to the fruit fly model.
  • Assessed rescue of behavioral and neurological defects, including short-term memory, courtship, and mushroom body function.

Related Experiment Videos

Main Results:

  • Treatment with mGluR antagonists successfully rescued short-term memory deficits in the Drosophila model.
  • Courtship behavior abnormalities were ameliorated by mGluR antagonist treatment.
  • Mushroom body defects, crucial for learning and memory in flies, were also rescued.

Conclusions:

  • These findings support the hypothesis that overactive group I mGluR signaling contributes to Fragile X syndrome.
  • Targeting mGluRs presents a potential therapeutic strategy for Fragile X syndrome.
  • The Drosophila model effectively recapitulates and allows for the testing of interventions for Fragile X syndrome-related cognitive and behavioral deficits.